Correlation of cancer related fatigue With respiratory muscle strength in breast cancer patients undergoing radiotherapy at tertiary health care hospital
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/05/052591
- Lead Sponsor
- Amar Damle
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Breast cancer patients undergoing
radiotherapy
Patient willing to give written consent
Exclusion Criteria
Chronic conditions (stroke, Chronic Obstructive
Pulmonary Disease, Lung pathology)
Any Metastatic breast cancer patient
Not willing to participate
Illiterate patients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cancer-related fatigueTimepoint: At Base line and 3 weeks ie after the radiotherapy session ( after 15 cycle)
- Secondary Outcome Measures
Name Time Method maximum inspiratory pressure maximum expiratory pressureTimepoint: at baseline and after 3 weeks ie after completion of radiotherapy session ( 15 cycle)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link cancer-related fatigue to respiratory muscle weakness in breast cancer patients post-radiotherapy?
How does respiratory muscle strength assessment compare with standard fatigue scales in predicting outcomes for breast cancer patients undergoing radiotherapy?
Are there specific biomarkers associated with respiratory muscle strength that can predict cancer-related fatigue severity in breast cancer patients receiving radiotherapy?
What are the potential adverse events of respiratory muscle training interventions in breast cancer patients during radiotherapy and how can they be managed?
How do respiratory muscle strength parameters in breast cancer patients correlate with other fatigue-related biomarkers such as cytokine levels or mitochondrial dysfunction markers during radiotherapy?